Skip to main content
. 2012 Feb 21;7(2):e32191. doi: 10.1371/journal.pone.0032191

Figure 4. Picropodophyllin treatment decreases IGFR1 signaling and downstream AKT and ERK signaling.

Figure 4

A) IGFR1 Y1136 Phosphorylation was inhibited with picropodophyllin (PPP). A random pharmacologic control drug, PHA, had no effect on IGFR1 phosphorylation. B) PPP treatment significantly decreases downstream AKT S473 phosphorylation and ERK p44/p42 phosphorylation (C). * denotes P<0.05 compared to control. (nā€Š=ā€Š3).